{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:41:03Z","timestamp":1789897263872,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,3,12]],"date-time":"2010-03-12T00:00:00Z","timestamp":1268352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s11910-010-0103-9","type":"journal-article","created":{"date-parts":[[2010,3,11]],"date-time":"2010-03-11T06:27:17Z","timestamp":1268288837000},"page":"215-223","source":"Crossref","is-referenced-by-count":64,"title":["The Genetics of Pediatric Brain Tumors"],"prefix":"10.1007","volume":"10","author":[{"given":"Adrian M.","family":"Dubuc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Northcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,12]]},"reference":[{"key":"103_CR1","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S1474-4422(07)70289-2","volume":"6","author":"JR Crawford","year":"2007","unstructured":"Crawford JR, MacDonald TJ, Packer RJ: Medulloblastoma in childhood: new biological advances. Lancet Neurol 2007, 6:1073\u20131085.","journal-title":"Lancet Neurol"},{"key":"103_CR2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.pathmechdis.3.121806.151518","volume":"3","author":"RJ Gilbertson","year":"2008","unstructured":"Gilbertson RJ, Ellison DW: The origins of medulloblastoma subtypes. Annu Rev Pathol 2008, 3:341\u2013365.","journal-title":"Annu Rev Pathol"},{"key":"103_CR3","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/00006123-200010000-00020","volume":"47","author":"MD Taylor","year":"2000","unstructured":"Taylor MD, Mainprize TG, Rutka JT: Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a review. Neurosurgery 2000, 47:888\u2013901.","journal-title":"Neurosurgery"},{"key":"103_CR4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0092-8674(00)81268-4","volume":"85","author":"H Hahn","year":"1996","unstructured":"Hahn H, Wicking C, Zaphiropoulous PG, et al.: Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996, 85:841\u2013851.","journal-title":"Cell"},{"key":"103_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2004.11.008","volume":"11","author":"S Marino","year":"2005","unstructured":"Marino S: Medulloblastoma: developmental mechanisms out of control. Trends Mol Med 2005, 11:17\u201322.","journal-title":"Trends Mol Med"},{"key":"103_CR6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJM199503303321302","volume":"332","author":"SR Hamilton","year":"1995","unstructured":"Hamilton SR, Liu B, Parsons RE, et al.: The molecular basis of Turcot\u2019s syndrome. N Engl J Med 1995, 332:839\u2013847.","journal-title":"N Engl J Med"},{"key":"103_CR7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/348747a0","volume":"348","author":"S Srivastava","year":"1990","unstructured":"Srivastava S, Zou ZQ, Pirollo K, et al.: Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990, 348:747\u2013749.","journal-title":"Nature"},{"key":"103_CR8","doi-asserted-by":"crossref","first-page":"7613","DOI":"10.1158\/1078-0432.CCR-04-0499","volume":"10","author":"A Ray","year":"2004","unstructured":"Ray A, Ho M, Ma J, et al.: A clinicobiological model predicting survival in medulloblastoma. Clin Cancer Res 2004, 10:7613\u20137620.","journal-title":"Clin Cancer Res"},{"key":"103_CR9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng.336","volume":"41","author":"PA Northcott","year":"2009","unstructured":"\u2022\u2022 Northcott PA, Nakahara Y, Wu X, et al.: Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 2009, 41:465\u2013472. The largest high-resolution genomic profiling of pediatric brain tumors performed to date identified and characterized a novel mechanism by which medulloblastomas may deregulate the transcriptome through aberrant histone modifications.","journal-title":"Nat Genet"},{"key":"103_CR10","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1200\/JCO.2008.17.9432","volume":"27","author":"S Pfister","year":"2009","unstructured":"\u2022 Pfister S, Remke M, Benner A, et al.: Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol 2009, 27:1627\u20131636. Pfister et al. identified an elegant molecular stratification system for medulloblastomas based on the DNA copy number status of only four genomic loci.","journal-title":"J Clin Oncol"},{"key":"103_CR11","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1158\/1078-0432.CCR-04-0465","volume":"11","author":"E Pan","year":"2005","unstructured":"Pan E, Pellarin M, Holmes E, et al.: Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients. Clin Cancer Res 2005, 11:4733\u20134740.","journal-title":"Clin Cancer Res"},{"key":"103_CR12","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1158\/0008-5472.CAN-08-4710","volume":"69","author":"PA Northcott","year":"2009","unstructured":"Northcott PA, Fernandez LA, Hagan JP, et al.: The miR-17\/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res 2009, 69:3249\u20133255.","journal-title":"Cancer Res"},{"key":"103_CR13","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0809579106","volume":"106","author":"T Uziel","year":"2009","unstructured":"Uziel T, Karginov FV, Xie S, et al.: The miR-17\u2009\u223c\u200992 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci U S A 2009, 106:2812\u20132817.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"103_CR14","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.4161\/cc.5.22.3446","volume":"5","author":"SC Clifford","year":"2006","unstructured":"Clifford SC, Lusher ME, Lindsey JC, et al.: Wnt\/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. Cell Cycle 2006, 5:2666\u20132670.","journal-title":"Cell Cycle"},{"key":"103_CR15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","volume":"7","author":"A Gajjar","year":"2006","unstructured":"Gajjar A, Chintagumpala M, Ashley D, et al.: Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 2006, 7:813\u2013820.","journal-title":"Lancet Oncol"},{"key":"103_CR16","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1200\/JCO.2005.04.4974","volume":"24","author":"MC Thompson","year":"2006","unstructured":"\u2022 Thompson MC, Fuller C, Hogg TL, et al.: Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 2006, 24:1924\u20131931. This study and the one by Kool et al. [17\u2022] were the first to describe distinct molecular subgroups of medulloblastoma using gene expression profiling and specific genomic features for a large cohort of tumors.","journal-title":"J Clin Oncol"},{"key":"103_CR17","doi-asserted-by":"crossref","first-page":"e3088","DOI":"10.1371\/journal.pone.0003088","volume":"3","author":"M Kool","year":"2008","unstructured":"\u2022 Kool M, Koster J, Bunt J, et al.: Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 2008, 3:e3088. This study and the one by Thompson et al. [16\u2022] were the first to describe distinct molecular subgroups of medulloblastoma using gene expression profiling and specific genomic features for a large cohort of tumors.","journal-title":"PLoS One"},{"key":"103_CR18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ccr.2005.09.001","volume":"8","author":"MD Taylor","year":"2005","unstructured":"Taylor MD, Poppleton H, Fuller C, et al.: Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005, 8:323\u20133235.","journal-title":"Cancer Cell"},{"key":"103_CR19","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00381-009-0928-1","volume":"25","author":"SC Mack","year":"2009","unstructured":"Mack SC, Taylor MD: The genetic and epigenetic basis of ependymoma. Childs Nerv Syst 2009, 25:1195\u20131201.","journal-title":"Childs Nerv Syst"},{"key":"103_CR20","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1200\/JCO.2006.06.3701","volume":"24","author":"P Modena","year":"2006","unstructured":"\u2022 Modena P, Lualdi E, Facchinetti F, et al.: Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 2006, 24:5223\u20135233. Modena et al. report one of the few genome-wide copy number studies in ependymoma. This study, with a modest sample size, identified both broad and focal genetic alterations and incorporated gene expression analysis.","journal-title":"J Clin Oncol"},{"key":"103_CR21","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/1078-0432.CCR-05-2363","volume":"12","author":"F Mendrzyk","year":"2006","unstructured":"Mendrzyk F, Korshunov A, Benner A, et al.: Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin Cancer Res 2006, 12:2070\u20132079.","journal-title":"Clin Cancer Res"},{"key":"103_CR22","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1200\/JCO.2007.15.4195","volume":"27","author":"S Puget","year":"2009","unstructured":"\u2022 Puget S, Grill J, Valent A, et al.: Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas. J Clin Oncol 2009, 27:1884\u20131892. This study, the most recent genome-wide copy number study in ependymoma, demonstrated deregulation of several Notch family members and found several regions of genomic alteration associated with tumor recurrence.","journal-title":"J Clin Oncol"},{"key":"103_CR23","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2189::AID-CNCR27>3.0.CO;2-G","volume":"88","author":"AT Reddy","year":"2000","unstructured":"Reddy AT, Janss AJ, Phillips PC, et al.: Outcome for children with supratentorial primitive neuroectodermal tumours treated with surgery, radiation and chemotherapy. Cancer 2000, 88:2189\u20132193.","journal-title":"Cancer"},{"key":"103_CR24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/415436a","volume":"415","author":"SL Pomeroy","year":"2002","unstructured":"Pomeroy SL, Tamayo P, Gaasenbeek M, et al.: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002, 415:436\u2013442.","journal-title":"Nature"},{"key":"103_CR25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2559.2005.02304.x","volume":"47","author":"MM Inda","year":"2005","unstructured":"Inda MM, Guilladu-Bataille M, Danglot G, et al.: Genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumours of the central nervous system. Histopathology 2005, 47:631\u2013637.","journal-title":"Histopathology"},{"key":"103_CR26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/gcc.20471","volume":"46","author":"S Pfister","year":"2007","unstructured":"\u2022 Pfister S, Remke M, Toedt G, et al.: Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastoma. Genes Chromosomes Cancer 2007, 46:839\u2013851. This report on the most recent comparative genomic hybridization investigation of sPNETs highlights previous findings and describes the first identification of chromosome 17 aberrations in sPNETs.","journal-title":"Genes Chromosomes Cancer"},{"key":"103_CR27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<331::AID-CNCR18>3.0.CO;2-#","volume":"86","author":"C Russo","year":"1999","unstructured":"Russo C, Pellarin M, Tingby O, et al.: Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer 1999, 86:331\u2013339.","journal-title":"Cancer"},{"key":"103_CR28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00005072-200606000-00003","volume":"65","author":"MG McCabe","year":"2006","unstructured":"McCabe MG, Ichimura K, Liu L, et al.: High-resolution array-based comparative genomic hybridization of medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neuropathol Exp Neurol 2006, 65:549\u2013561.","journal-title":"J Neuropathol Exp Neurol"},{"key":"103_CR29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2990.2002.00413.x","volume":"28","author":"JA Kraus","year":"2002","unstructured":"Kraus JA, Felsberg J, Tonn JC, et al.: Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood. Neuropathol Appl Neurobiol 2002, 28:325\u2013333.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"103_CR30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","volume":"64","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki H, Kleihues P: Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005, 64:479\u2013489.","journal-title":"J Neuropathol Exp Neurol"},{"key":"103_CR31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.21107","volume":"61","author":"R Listernick","year":"2007","unstructured":"Listernick R, Ferner RE, Liu GT, Gutmann DH: Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 2007, 61:189\u2013198.","journal-title":"Ann Neurol"},{"key":"103_CR32","doi-asserted-by":"crossref","first-page":"26958","DOI":"10.1074\/jbc.M209413200","volume":"278","author":"S Yunoue","year":"2003","unstructured":"Yunoue S, Tokuo H, Fukunaga K, et al.: Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras. J Biol Chem 2003, 278:26958\u201326969.","journal-title":"J Biol Chem"},{"key":"103_CR33","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/0008-5472.CAN-06-0973","volume":"67","author":"MK Sharma","year":"2007","unstructured":"Sharma MK, Mansur DB, Reifenberger G, et al.: Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res 2007, 67:890\u2013900.","journal-title":"Cancer Res"},{"key":"103_CR34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2007-984451","volume":"38","author":"WG Janzarik","year":"2007","unstructured":"Janzarik WG, Kratz CP, Loges NT, et al.: Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. Neuropediatrics 2007, 38:61\u201363.","journal-title":"Neuropediatrics"},{"key":"103_CR35","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1212\/01.wnl.0000180409.78098.d7","volume":"65","author":"MK Sharma","year":"2005","unstructured":"Sharma MK, Zehnbauer BA, Watson MA, Gutmann DH: RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma. Neurology 2005, 65:1335\u20131336.","journal-title":"Neurology"},{"key":"103_CR36","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/01.jnen.0000240465.33628.87","volume":"65","author":"DT Jones","year":"2006","unstructured":"Jones DT, Ichimura K, Liu L, et al.: Genomic analysis of pilocytic astrocytomas at 0.97\u00a0Mb resolution shows an increasing tendency toward chromosomal copy number change with age. J Neuropathol Exp Neurol 2006, 65:1049\u20131058.","journal-title":"J Neuropathol Exp Neurol"},{"key":"103_CR37","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1054\/bjoc.1999.1066","volume":"82","author":"D Sanoudou","year":"2000","unstructured":"Sanoudou D, Tingby O, Ferguson-Smith MA, et al.: Analysis of pilocytic astrocytoma by comparative genomic hybridization. Br J Cancer 2000, 82:1218\u20131222.","journal-title":"Br J Cancer"},{"key":"103_CR38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/path.2558","volume":"218","author":"T Forshew","year":"2009","unstructured":"Forshew T, Tatevossian RG, Lawson AR, et al.: Activation of the ERK\/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol 2009, 218:172\u2013181.","journal-title":"J Pathol"},{"key":"103_CR39","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/sj.bjc.6605179","volume":"101","author":"K Jacob","year":"2009","unstructured":"Jacob K, Albrecht S, Sollier C, et al.: Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours. Br J Cancer 2009, 101:722\u2013733.","journal-title":"Br J Cancer"},{"key":"103_CR40","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1172\/JCI33656","volume":"118","author":"S Pfister","year":"2008","unstructured":"\u2022\u2022 Pfister S, Janzarik WG, Remke M, et al.: BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 2008, 118:1739\u20131749. This was the first study to describe BRAF duplications in more than 50% of PAs and activating BRAF mutations in nonoverlapping cases.","journal-title":"J Clin Invest"},{"key":"103_CR41","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/NEN.0b013e3181845622","volume":"67","author":"EE Bar","year":"2008","unstructured":"Bar EE, Lin A, Tihan T, et al.: Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol 2008, 67:878\u2013887.","journal-title":"J Neuropathol Exp Neurol"},{"key":"103_CR42","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","volume":"68","author":"DT Jones","year":"2008","unstructured":"\u2022 Jones DT, Kocialkowski S, Liu L, et al.: Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 2008, 68:8673\u20138677. This study and the one by Sievert et al. [43\u2022] were the first to identify BRAF fusion transcripts in PA with loss of the autoinhibitory domain.","journal-title":"Cancer Res"},{"key":"103_CR43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1750-3639.2008.00225.x","volume":"19","author":"AJ Sievert","year":"2009","unstructured":"\u2022 Sievert AJ, Jackson EM, Gai X, et al.: Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. Brain Pathol 2009, 19:449\u2013458. This study and the one by Jones et al. [42\u2022] were the first to identify BRAF fusion transcripts in PA with loss of the autoinhibitory domain.","journal-title":"Brain Pathol"},{"key":"103_CR44","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/onc.2009.73","volume":"28","author":"DT Jones","year":"2009","unstructured":"Jones DT, Kocialkowski S, Liu L, et al.: Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene 2009, 28:2119\u20132123.","journal-title":"Oncogene"},{"key":"103_CR45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00401-009-0550-z","volume":"118","author":"A Korshunov","year":"2009","unstructured":"Korshunov A, Meyer J, Capper D, et al.: Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Acta Neuropathol 2009, 118:401\u2013405.","journal-title":"Acta Neuropathol"},{"key":"103_CR46","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1093\/hmg\/ddm073","volume":"16","author":"RM Brena","year":"2007","unstructured":"Brena RM, Costello JF: Genome-epigenome interactions in cancer. Rev Hum Mol Genet 2007, 16:R96\u2013R105.","journal-title":"Rev Hum Mol Genet"},{"key":"103_CR47","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/foc.2005.19.5.11","volume":"19","author":"JC Lindsey","year":"2005","unstructured":"Lindsey JC, Anderton JA, Lusher ME, Clifford SC: Epigenetic events in medulloblastoma development. Neurosurg Focus 2005, 19:E10.","journal-title":"Neurosurg Focus"},{"key":"103_CR48","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1215\/15228517-2008-048","volume":"10","author":"JA Anderton","year":"2008","unstructured":"Anderton JA, Lindsey JC, Lusher ME, et al.: Global analysis of the medulloblastoma epigenome identifies disease subgroup-specific inactivation of COL1A2. Neuro Oncol 2008, 10:981\u2013994.","journal-title":"Neuro Oncol"},{"key":"103_CR49","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1158\/0008-5472.CAN-08-2169","volume":"68","author":"P Kongkham","year":"2008","unstructured":"\u2022 Kongkham P, Northcott PA, Ra YS, et al.: An epigenetic genome-wide screen identifies SPINT2 as a novel tumour suppressor gene in pediatric medulloblastoma. Cancer Res 2008, 68:9945\u20139953. Kongkham et al. report a novel approach integrating loss of heterozygosity and epigenetic data from pharmacologic screens to identify new pathways dysregulated in medulloblastoma.","journal-title":"Cancer Res"},{"key":"103_CR50","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/nar\/gkm094","volume":"35","author":"S Pfister","year":"2007","unstructured":"\u2022 Pfister S, Schlaeger C, Mendrzyk F, et al.: Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma. Nucleic Acids Res 2007, 35:e51. Pfister et al. examined novel DNA hypermethylation events in primary medulloblastomas. Their report describes a clinical correlation between aberrant methylation and overall survival outcome and identifies ZIC2 as a frequent target of epigenetic silencing.","journal-title":"Nucleic Acids Res"},{"key":"103_CR51","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.onc.1209137","volume":"25","author":"J Muhlisch","year":"2006","unstructured":"Muhlisch J, Schwering, A, Grotzer M, et al.: Epigenetic represison of RASSF1A but not CASP8 in supratentorial PNETs (sPNET) and atypical teratoid rhabdoid tumours (AT\/RT) of childhood. Oncogene 2006, 25:1111\u20131117.","journal-title":"Oncogene"},{"key":"103_CR52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.humpath.2004.09.021","volume":"36","author":"JC-S Pang","year":"2005","unstructured":"Pang JC-S, Chang Q, Chung, YF, et al.: Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumours. Hum Pathol 2005, 36:36\u201343.","journal-title":"Hum Pathol"},{"key":"103_CR53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2559.2006.02374.x","volume":"48","author":"MM Inda","year":"2006","unstructured":"Inda MM, Munoz J, Coullin P, et al.: High promoter hypermethylation frequency of p14\/ARF in supratentorial PNET but not in medulloblastoma. Histopathology 2006, 48:579\u2013587.","journal-title":"Histopathology"},{"key":"103_CR54","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ng.159","volume":"40","author":"Y Kondo","year":"2008","unstructured":"Kondo Y, Shen L, Cheng AS, et al.: Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 2008, 40:741\u2013750.","journal-title":"Nat Genet"},{"key":"103_CR55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-540-31206-2_4","volume":"171","author":"S Pfister","year":"2009","unstructured":"Pfister S, Witt O: Pediatric gliomas. Recent Results Cancer Res 2009, 171:67\u201381.","journal-title":"Recent Results Cancer Res"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-010-0103-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-010-0103-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-010-0103-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:28:18Z","timestamp":1559435298000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-010-0103-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,12]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["103"],"URL":"https:\/\/doi.org\/10.1007\/s11910-010-0103-9","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,12]]}}}